세계의 지혈 진단 시장 규모 조사 및 예측 : 제품별, 검사 유형별, 최종 용도별, 지역별 분석(2023-2030년)

Global Hemostasis Diagnostics Market is valued approximately USD 6.41 million in 2022 and is anticipated to grow with a healthy growth rate of more than 8.60% over the forecast period 2023-2030. Hemostasis diagnostic devices help discover hemostatic disorders that cause excessive bleeding. During hemostasis, blood transforms from liquid to gelatinous. Hemostasis is a technique that the body uses after an injury to limit blood loss and cease blood flow. Following this, there are three further steps: vasoconstriction, platelet plug formation, and blood coagulation. Rising blood clotting diagnostic rates among patients, particularly those who are more prone to losing extra blood from the body after procedures, are important reasons driving market expansion. The growth in the incidence of many diseases such as cancer, diabetes, and neurological disorders, as well as the increase in the older population and lifestyle changes, drive the hemostasis diagnostics market. During the projected period, the worldwide hemostasis diagnostics market is expected to be driven by an increase in the prevalence of haemophilia.

Rising incidents of blood clotting disorders, technical developments in medical treatment, and increased acceptance of automated hemostasis equipment are all having an impact on the growth of the market under consideration. According to the World Bleeding Disorders Registry 2021 report, a survey of 37 countries reported 9,414 people with haemophilia as of December 2021, with South-East Asia having the highest prevalence with 2,828 affected individuals, followed by the Eastern Mediterranean and Africa with 2,418 and 1,027 affected individuals, respectively. Additionally, growing continuous advancement in research and development initiatives to miniaturize molecular and professional diagnostic testing is anticipated to create the lucrative opportunity for the market during forecast period. However, a lack of awareness about hemostasis diseases in developing regions, in addition to stringent government regulations, might hinder the market growth throughout the forecast period of 2023-2030

The key regions considered for the Global Hemostasis Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the widespread use of powerful automated analyzers, the availability of a large patient pool, and the high frequency of blood clot illnesses, and supportive government initiatives. Asia Pacific is expected to grow significantly during the forecast period, the region's rapid market rise can be ascribed to several government efforts aimed at improving health-care infrastructure. The market in the area is expected to grow significantly in comparison to other regions, owing to a change in the base of pharmaceutical businesses and clinical research industries from developed to emerging nations such as China and India.

Major market player included in this report are:

• Abbott
• Thermo Fisher Scientific Inc.
• HORIBA Europe Holding
• Medtronic
• Technidyne Corporation
• Grifols S.A
• F. Hoffmann-La Roche Ltd.
• NIHON KOHDEN CORPORATION
• Haemonetics Corporation
• Beckman Coulter Inc.

Recent Developments in the Market:

• In December 2022, the US FDA granted HemoSonics' Quantra Hemostasis System with QStat Cartridge 510(k) commercial approval The QStat Cartridge test, according to the manufacturer, expands Quantra's total diagnostic capabilities. The newest point-of-care hemostasis analyzer in the United States, the next-generation whole-blood hemostasis system, covers the broadest range of clinical purposes.
• In November 2022, a Dutch company, Enzyre, which is developing ambulant diagnostic technology for blood coagulation testing, successfully raised USD 11.9 million (EUR 12 million) in series A funding to help hemophilia patients test from home

Global Hemostasis Diagnostics Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimatio: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Product, Test Type, End Use, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

• Laboratory Analyzers
• Point-of-Care Testing Systems

By Test Type:

• Activated Partial Thromboplastin Time
• D Dimer Test
• Fibrinogen Test
• Prothrombin Time Test
• Activated Clotting Time
• Platelet Aggregation Test

By End Use:

• Hospitals
• Diagnostic Centers
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
  • 1.2.1. Hemostasis Diagnostics Market, by Region, 2020-2030 (USD Million)
  • 1.2.2. Hemostasis Diagnostics Market, by Product, 2020-2030 (USD Million)
  • 1.2.3. Hemostasis Diagnostics Market, by Test Type, 2020-2030 (USD Million)
  • 1.2.4. Hemostasis Diagnostics Market, by End Use, 2020-2030 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Hemostasis Diagnostics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Hemostasis Diagnostics Market Dynamics

• 3.1. Hemostasis Diagnostics Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising Incidences of Blood Clotting Disorders
    • 3.1.1.2. Rising Adoption of Automated Hemostasis Equipment
  • 3.1.2. Market Challenges
    • 3.1.2.1. Stringent Government Regulation
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Advancements in R&D

Chapter 4. Global Hemostasis Diagnostics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Hemostasis Diagnostics Market, by Product

• 5.1. Market Snapshot
• 5.2. Global Hemostasis Diagnostics Market by Product, Performance - Potential Analysis
• 5.3. Global Hemostasis Diagnostics Market Estimates & Forecasts by Product 2020-2030 (USD Million)
• 5.4. Hemostasis Diagnostics Market, Sub Segment Analysis
  • 5.4.1. Laboratory Analyzers
  • 5.4.2. Point-of-Care Testing Systems

Chapter 6. Global Hemostasis Diagnostics Market, by Test Type

• 6.1. Market Snapshot
• 6.2. Global Hemostasis Diagnostics Market by Test Type, Performance - Potential Analysis
• 6.3. Global Hemostasis Diagnostics Market Estimates & Forecasts by Test Type 2020-2030 (USD Million)
• 6.4. Hemostasis Diagnostics Market, Sub Segment Analysis
  • 6.4.1. Activated Partial Thromboplastin Time
  • 6.4.2. D Dimer Test
  • 6.4.3. Fibrinogen Test
  • 6.4.4. Prothrombin Time Test
  • 6.4.5. Activated Clotting Time
  • 6.4.6. Platelet Aggregation Test

Chapter 7. Global Hemostasis Diagnostics Market, by End Use

• 7.1. Market Snapshot
• 7.2. Global Hemostasis Diagnostics Market by End Use, Performance - Potential Analysis
• 7.3. Global Hemostasis Diagnostics Market Estimates & Forecasts by End Use 2020-2030 (USD Million)
• 7.4. Hemostasis Diagnostics Market, Sub Segment Analysis
  • 7.4.1. Hospitals
  • 7.4.2. Diagnostic Centers
  • 7.4.3. Others

Chapter 8. Global Hemostasis Diagnostics Market, Regional Analysis

• 8.1. Top Leading Countries
• 8.2. Top Emerging Countries
• 8.3. Hemostasis Diagnostics Market, Regional Market Snapshot
• 8.4. North America Hemostasis Diagnostics Market
  • 8.4.1. U.S. Hemostasis Diagnostics Market
    • 8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2. Test Type breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3. End Use breakdown estimates & forecasts, 2020-2030
  • 8.4.2. Canada Hemostasis Diagnostics Market
• 8.5. Europe Hemostasis Diagnostics Market Snapshot
  • 8.5.1. U.K. Hemostasis Diagnostics Market
  • 8.5.2. Germany Hemostasis Diagnostics Market
  • 8.5.3. France Hemostasis Diagnostics Market
  • 8.5.4. Spain Hemostasis Diagnostics Market
  • 8.5.5. Italy Hemostasis Diagnostics Market
  • 8.5.6. Rest of Europe Hemostasis Diagnostics Market
• 8.6. Asia-Pacific Hemostasis Diagnostics Market Snapshot
  • 8.6.1. China Hemostasis Diagnostics Market
  • 8.6.2. India Hemostasis Diagnostics Market
  • 8.6.3. Japan Hemostasis Diagnostics Market
  • 8.6.4. Australia Hemostasis Diagnostics Market
  • 8.6.5. South Korea Hemostasis Diagnostics Market
  • 8.6.6. Rest of Asia Pacific Hemostasis Diagnostics Market
• 8.7. Latin America Hemostasis Diagnostics Market Snapshot
  • 8.7.1. Brazil Hemostasis Diagnostics Market
  • 8.7.2. Mexico Hemostasis Diagnostics Market
• 8.8. Middle East & Africa Hemostasis Diagnostics Market
  • 8.8.1. Saudi Arabia Hemostasis Diagnostics Market
  • 8.8.2. South Africa Hemostasis Diagnostics Market
  • 8.8.3. Rest of Middle East & Africa Hemostasis Diagnostics Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
  • 9.1.1. Company 1
  • 9.1.2. Company 2
  • 9.1.3. Company 3
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Abbott
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Recent Developments
  • 9.3.2. Thermo Fisher Scientific Inc.
  • 9.3.3. HORIBA Europe Holding
  • 9.3.4. Medtronic
  • 9.3.5. Technidyne Corporation
  • 9.3.6. Grifols S.A
  • 9.3.7. F. Hoffmann-La Roche Ltd.
  • 9.3.8. NIHON KOHDEN CORPORATION
  • 9.3.9. Haemonetics Corporation
  • 9.3.10. Beckman Coulter Inc.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption